Entrusted financial announcement
Release time:
2021-05-20
证券简称:尖峰集团 证券代码:600668 编号:临2020-012
浙江尖峰集团股份有限公司
委托理财公告
本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。
重要内容提示:
- 委托理财受托方:华夏银行股份有限公司金华分行
- 委托理财金额:10,000万元人民币
- 委托理财产品名称:慧盈人民币单位结构性存款产品20231753
- 委托理财投资类型:保本浮动收益型结构性存款
- 委托理财期限:2020年5月12日—2020年8月12日
- 履行的审议程序:2019年4月26日,公司召开的第十届董事会第10次会议审议通过了《关于授权公司董事长利用自有资金进行委托理财的议案》。授权公司董事长行使不超过人民币5亿元的委托理财的决策权,在该额度内资金可以滚动使用,但任一时点存续的委托理财余额合计不得超过5亿元,每笔委托理财的期限均不得超过12个月。详见本公司在2019年4月30日在上海证券交易所网站等披露的《关于授权公司董事长利用自有资金进行委托理财的公告》(临2019-012)。
一、本次委托理财概况
(一)委托理财目的
公司在不影响主营业务的正常开展、日常运营资金周转需要和资金安全的前提下,使用暂时闲置自有资金10,000万元购买华夏银行金华分行发售的慧盈人民币单位结构性存款产品。本产品为保本浮动收益型存款产品,安全性高、流动性好、风险性低。公司通过进行适度的低风险理财产品投资业务,有利于提高资金使用效率,且获得一定的理财收益。
(二)资金来源
本次委托理财的资金来源系公司自有资金。
(三)委托理财产品的基本情况
|
受托方 名称 |
产品 类型 |
产品 名称 |
金额 (万元) |
预计年化 收益率 |
预计收益金额 (万元) |
|
华夏银行股份有限公司金华分行 |
银行结构性存款产品 |
慧盈人民币单位结构性存款产品 |
10,000 |
1.54%—3.80% |
38.82-95.78 |
|
产品 期限 |
收益 类型 |
结构化 安排 |
参考年化 收益率 |
预计收益 (万元) |
是否构成 关联交易 |
|
92天 |
保本浮动收益型 |
无 |
1.54%—3.80% |
38.82-95.78 |
否 |
(四)公司对委托理财相关风险的内部控制
1、委托理财情况由公司审计部门进行日常监督,定期对公司委托理财的进展情况、盈亏情况、风险控制情况和资金使用情况进行审计、核实。
2、公司进行委托理财,应当选择资信、财务状况良好、盈利能力强的合格专业理财机构作为受托方,并与受托方签订书面合同,明确委托理财的金额、期间、投资品种、双方的权利义务及法律责任等,必要时要求提供担保。公司董事会指派公司财务负责人跟踪委托理财的进展情况及投资安全状况。财务负责人发现公司委托理财出现异常情况时应当及时向董事会报告,以便董事会立即采取有效措施回收资金,避免或减少公司损失。
3、公司独立董事可以对委托理财情况进行检查。独立董事在公司内部审计核查的基础上,以董事会审计委员会核查为主,必要时由二名以上独立董事提议,有权聘任独立的外部审计机构进行委托理财的专项审计。独立董事应对提交董事会审议的委托理财事项发表独立意见。
4、公司监事会有权对公司委托理财情况进行定期或不定期的检查。如发现违规操作情况可提议召开董事会审议停止公司的相关投资活动。
5、公司委托理财具体执行人员及其他知情人员在相关信息公开披露前不得将公司投资情况透露给其他个人或组织,但法律、法规或规范性文件另有规定的除外。
6、凡违反相关法律法规、本制度及公司其他规定或由于工作不尽职,致使公司遭受损失或收益低于预期,将视具体情况,追究相关人员的责任。
本次公司购买华夏银行发行的保本浮动收益型结构性存款,在前述董事会对董事长的授权范围内,该产品风险程度低,符合公司内部资金管理要求。
二、本次委托理财的具体情况
(一)委托理财合同主要条款
客户:浙江尖峰集团股份有限公司
银行:华夏银行股份有限公司金华分行
|
产品名称 |
慧盈人民币单位结构性存款产品20231753 |
|
产品代码 |
HY20231753 |
|
挂钩标的 |
上海期货交易所黄金期货价格AU2012 (以下简称“黄金期货价格”) |
|
产品期限 |
92天 |
|
产品类型 |
保本浮动收益型存款产品 |
|
本金保证 |
银行在本产品到期时保证存款本金 |
|
存款成立日 |
2020年5月12日 |
|
存款到期日 |
2020年8月12日 |
|
本金及收益支付 |
2020年8月12日,产品正常到期;如产品因故提前终止的,则到期日以华夏银行通知为准。 产品到期日当日不计算收益,华夏银行于到期日当日的22:30至24:00一次性支付本金及收益。 |
|
预期年化收益率 |
根据产品挂钩标的表现,预期年化收益率在1.54%至3.80%之间(详见“产品收益分析与计算”): 1、若观察期挂钩标的收盘价格均小于障碍价格,且结算价格大于或等于执行价格1,则预期年化收益率 =3.80% 2、若观察期挂钩标的收盘价格均小于障碍价格,且结算价格小于执行价格1,则预期年化收益率 =3.70% 3、若观察期任一交易日挂钩标的收盘价格大于或等于障碍价格,且结算价格大于或等于执行价格2,则预期年化收益率 =3.70% 4、若观察期任一交易日挂钩标的收盘价格大于或等于障碍价格,且结算价格小于执行价格2,则预期年化收益率=1.54% |
|
提前终止权 |
一、客户提前终止权 1、除非出现如下任一情形,否则客户无权提前终止本产品: (1)华夏银行根据法律法规、监管规定或市场重大变动对本产品的投资范围、投资品种或投资比例进行调整,客户不接受上述调整的; (2)华夏银行根据法律法规、监管规定或国家政策规定,对本产品的收费项目、条件、标准和方式进行调整,客户不接受上述调整的; 2、华夏银行对本产品做调整的,将通过销售人员通知客户。客户不接受调整的,应在通知确定的期限内向华夏银行申请提前终止并办理相关手续;若投资者在期限届满继续持有本产品,则视为接受对本产品的调整。 二、华夏银行提前终止权 1、出现下列情形,华夏银行有权提前终止本产品: (1)遇国家法律法规或金融政策出现重大调整并影响本产品正常运作; (2)根据市场及投资运作情况经华夏银行合理判断认为需要提前终止本产品。 2、华夏银行提前终止本产品的,在提前终止日前3个工作日通过销售人员告知客户。 由于华夏银行在特定情况下提前终止本产品,本产品的实际期限可能小于预定期限。如果本产品提前终止,则投资者将无法实现期初预期的全部收益。 |
|
预期收益计算方法 |
预期收益=存款本金×预期年化收益率×产品期限÷365 |
|
税款 |
产品收益的应纳税款由投资者自行申报及缴纳,但若根据法律法规等规定或税务等国家机关的命令或要求,华夏银行有义务代扣代缴投资者承担的税费时,华夏银行将进行代扣代缴。 |
|
其他规定 |
1、认购申请日(含)至认购撤销日(不含),客户资金按华夏银行每日挂牌活期存款利率计算利息。 2、认购申请日(含)至成立日(不含),客户资金按华夏银行每日挂牌活期存款利率计算利息,且该利息不计入认购本金。 |
(二)委托理财的资金投向
本次公司委托理财的资金投向为华夏银行结构性存款产品。
(三)风险控制分析
公司本次使用自有资金购买华夏银行金华分行发售的保本浮动收益型结构性存款,在公司第十届董事会第10次会议授权董事长决策范围之内。公司财务部建立台账负责对短期理财产品进行管理,建立健全会计账目,做好资金使用的财务核算工作。公司在本次交易后将履行信息披露义务,并实时跟踪进展情况及时披露。
华夏银行结构性存款属于保本浮动收益型产品,华夏银行股份有限公司金华分行承诺保障结构性存款本金,因此该产品风险程度较低,符合公司《委托理财管理制度》的要求。
三、委托理财受托方的情况
(一)受托方的基本情况
|
名称 |
成立时间 |
法定代表人 |
注册 资本 (万元) |
主营业务 |
主要股东及实际控制人 |
是否为本次交易专设 |
|
华夏银行股份有限公司 |
1992-10-14 |
李民吉 |
1538722.3983 |
吸收公众存款;发放短期、中期和长期贷款;办理国内外结算;办理票据承兑与贴现;发行金融债券;代理发行、代理兑付、承销政府债券;买卖政府债券、金融债券;从事同业拆借;买卖、代理买卖外汇;从事银行卡业务;提供信用证服务及担保;代理收付款项;提供保管箱服务;结汇、售汇业务;保险兼业代理业务;经中国银行业监督管理委员会批准的其他业务。(企业依法自主选择经营项目,开展经营活动;依法须经批准的项目,经相关部门批准后依批准的内容开展经营活动;不得从事本市产业政策禁止和限制类项目的经营活动。) |
首钢集团有限公司、国网英大国际控股集团有限公司、中国人民财产保险股份有限公司等 |
否 |
(二)受托方最近一年又一期主要财务指标
单位:百万元
|
|
2019年12月31日 |
2020年3月31日 |
|
总资产 |
3,020,789 |
3,108,998 |
|
归属于股东的净资产 |
267,588 |
272,846 |
|
|
2019年度 |
2020年1-3月 |
|
营业收入 |
84,734 |
23,594 |
|
归属于股东的净利润 |
21,905 |
4,840 |
(三)华夏银行股份有限公司与本公司之间在产权、业务、资产、债权债务、人员等方面均不存在关联关系。
四、对公司的影响
(一)本公司最近一年又一期主要财务指标
单位:万元
|
项目 |
2019年12月31日 |
2020年3月31日 |
|
总资产 |
547,517.79 |
561,077.58 |
|
总负债 |
139,487.88 |
143,631.62 |
|
归属于公司股东的净资产 |
378,910.99 |
391,427.86 |
|
|
2019年度 |
2020年1-3月 |
|
经营性现金流量净额 |
51,998.13 |
-2,709.08 |
|
营业收入 |
354,753.76 |
53,758.84 |
|
归属于公司股东的净利润 |
72,468.81 |
12,265.65 |
公司本次购买华夏银行结构性存款理财产品是在不影响主营业务的正常开展、日常运营资金周转需要和资金安全的前提下,使用短期闲置自有资金进行委托理财业务,有利于提高公司资金使用效率。
(二)截止2020年3月31日,公司货币资金为45,084.20万元,本次购买华夏银行结构性存款支付的金额占最近一期期末货币资金的22.18%,对本公司未来主营业务、财务状况、经营成果和现金流量等不会造成重大的影响。
(三)根据企业会计准则第22号—《金融工具确认和计量》规定,该结构性银行存款符合以摊余成本计量的金融资产,列示于资产负债表—其他流动资产,利息收益计入利润表—投资收益。
五、风险提示
尽管本公司购买的结构性存款属于短期保本浮动收益型的低风险理财产品,但金融市场受宏观经济影响较大,不排除该项投资受到市场风险、信用风险、政策风险、流动性风险、不可抗力风险等风险从而影响收益。
六、独立董事意见
公司召开的第十届董事会第10次会议审议通过了《关于授权公司董事长决定委托理财的议案》,独立董事发表了独立意见,认为:该决议的形成符合《公司法》、公司《章程》等有关规定,没有损害中小股东的利益。
七、截至本公告日,公司最近十二个月使用自有资金或募集资金委托理财的情况 单位:万元
|
序号 |
理财产品类型 |
实际投入 金额 |
实际收回 本金 |
实际收益 |
尚未收回 本金金额 |
|
1 |
汇利丰2019年5015期对公定制人民币结构性存款产品 |
10,000.00 |
10,000.00 |
104.71 |
/ |
|
2 |
薪加薪16号人民币结构性存款产品 |
8,000.00 |
8,000.00 |
136.32 |
/ |
|
3 |
薪加薪16号人民币结构性存款产品 |
8,000.00 |
8,000.00 |
115.51 |
/ |
|
4 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
5,000.00 |
48.70 |
/ |
|
5 |
慧盈人民币单位结构性存款产品 |
5,000.00 |
5,000.00 |
50.03 |
/ |
|
6 |
薪加薪16号人民币结构性存款产品 |
4,000.00 |
4,000.00 |
27.34 |
/ |
|
7 |
渤海银行S190019号结构性存款理财产品 |
10,000.00 |
10,000.00 |
99.73 |
/ |
|
8 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
10,000.00 |
33.75 |
/ |
|
9 |
渤海银行S191620号结构性存款理财产品 |
5,000.00 |
5,000.00 |
50.49 |
/ |
|
10 |
渤海银行S192012号结构性存款理财产品 |
3,000.00 |
3,000.00 |
29.92 |
/ |
|
11 |
慧盈人民币单位结构性存款产品 |
3,000.00 |
3,000.00 |
29.96 |
/ |
|
12 |
薪加薪16号人民币结构性存款产品 |
5,000.00 |
/ |
/ |
5,000.00 |
|
13 |
结构性存款 |
5,000.00 |
5,000.00 |
18.74 |
/ |
|
14 |
慧盈人民币单位结构性存款产品 |
5,000.00 |
/ |
/ |
5,000.00 |
|
15 |
薪加薪16号人民币结构性存款产品 |
10,000.00 |
/ |
/ |
10,000.00 |
|
16 |
慧盈人民币单位结构性存款产品 |
10,000.00 |
/ |
/ |
10,000.00 |
|
合计 |
106,000.00 |
76,000.00 |
745.20 |
30,000.00 |
|
|
最近12个月内单日最高投入金额 |
50,000.00 |
||||
|
最近12个月内单日最高投入金额/最近一年净资产(%) |
13.20 |
||||
|
最近12个月委托理财累计收益/最近一年净利润(%) |
1.03 |
||||
|
目前已使用的理财额度 |
30,000.00 |
||||
|
尚未使用的理财额度 |
20,000.00 |
||||
|
总理财额度 |
50,000.00 |
||||
特此公告
浙江尖峰集团股份有限公司
董事会
二〇二〇年五月十三日
More information
On December 30, the group company held a special study meeting. Members of the group's party committee and management team concentrated on learning the spirit of the central economic work conference and the Zhejiang provincial party committee economic work conference. From December 16 to 18, the annual Central Economic Work Conference was held in Beijing, which made it clear that in 2021, "we should continue to implement a proactive fiscal policy and a prudent monetary policy, maintain the necessary support for economic recovery, be more accurate and effective in policy operation, do not make sharp turns, and grasp the effectiveness of the policy. It is necessary to make good use of the precious time window, concentrate on promoting reform and innovation, and take high-quality development as the general tone of the 14th five-year Plan. It is proposed to strengthen the national strategic scientific and technological strength, enhance the independent and controllable ability of the industrial chain supply chain, adhere to the strategic basis of expanding domestic demand, and comprehensively promote reform and opening up. On the 25th, the Zhejiang Provincial Party Committee Economic Work Conference was held in Hangzhou to make specific arrangements for the economic development of Zhejiang Province in 2021. At the study meeting, Jiang Xiaomeng, secretary of the party committee and chairman of the group company, together with the leaders attending the meeting, analyzed and studied the key issues raised at the economic work conference of the central and Zhejiang provincial party committees one by one. In his study and discussion, Jiang Xiaomeng stressed that the current neo-coronary pneumonia epidemic is still spreading around the world, the world economy is in a deep recession, the risk of strong stimulus policies in developed countries has spilled over, the global industrial chain supply chain cycle has been blocked, and international trade and investment have shrunk; major strategic achievements have been made in the prevention and control of the domestic epidemic, and the economy has recovered steadily, but there is still greater uncertainty of instability. China has turned to the stage of high-quality development, the economy has been improving for a long time, the development resilience is strong, and the overall social situation is stable. At the same time, the problem of unbalanced and inadequate development in China is still prominent, the reform task of key links in key areas is still arduous, and the innovation ability is not suitable; at present and in the future, China's development is still in an important period of strategic opportunities, but there are new development and changes in opportunities and challenges, we are accelerating the construction of a new development pattern with the domestic cycle as the main body and the domestic and international double cycle promoting each other. The economic work conference of the Central Committee and the Zhejiang provincial Party committee has set the tone and pointed the way for the future development of enterprises. Party organizations at all levels and enterprise management teams should seriously organize and study, deeply understand the spirit of the conference, correctly understand and judge the future policy direction and industry trend, scientifically plan the work of the new year in combination with the actual work of the enterprise, and promote the better development of the enterprise. (this newspaper reporter)
2021
01-04
A few days ago, Tianjin Jianfeng Flanders Company successfully passed the national high-tech enterprise re-identification review work, and once again joined the ranks of high-tech enterprises after the transformation of the enterprise. The original development orientation of Flanders is pharmaceutical excipients, which belongs to the biomedical industry supported by the state. Its products are mainly aimed at major pharmaceutical factories, with clear product standards and strong technical pertinence, so it has been recognized as a national high-tech enterprise for a long time. Starting from 2019, Flanders has embarked on an industrial transformation in the direction of healthy functional foods. The food industry has a variety of products and serves a wide range of people. Enterprises need to come up with products with unique value in order to be accepted and recognized by the market. The difficulty of identifying high-tech enterprises has also increased accordingly. In order to do a good job in the application evaluation of high-tech enterprises, Flanders, in addition to further combing the achievements of previous technological innovation, has also adjusted and established a high-level R & D team on the basis of establishing postdoctoral workstations in cooperation with Shenyang Pharmaceutical University and Tianjin University of traditional Chinese Medicine, and strengthened technological innovation and intellectual property protection in the direction of new industries. For more than a year, Flanders has successfully transformed, produced and put on the market a number of small molecule functional foods and special dietary products such as Huizhi Gold Drink. In order to further accelerate the pace of development in the health food industry, Flanders has successively joined the Tianjin Health Association, Tianjin Food Safety Association and other food industry organizations; and with the strong support of the Tianjin Association for Science and Technology, it began to prepare for the establishment of the Tianjin Medical and Health Society Health Industry Professional Committee. National high-tech enterprises identified once every three years. The person in charge of Flanders said that the company is currently in a critical period of development and transformation. The identification of high-tech enterprises is not only the recognition of the work of Flanders in the past two years by the competent authorities and the industry, but also will provide assistance to the future development of the company. In the future, Flanders will further increase its scientific research efforts, continue to develop and create new products with high-tech content, and make more contributions to public health. (Liu Hairong)
2020
12-22
On the afternoon of December 2, Sang Weiliang, secretary of the Qiandongnan Prefecture Party Committee of Guizhou Province, Wu Ming, deputy director of the Standing Committee of the State People's Congress, Long Zaichong, deputy secretary-general of the State Party Committee, and the main party and government leaders of Huangping County visited Huangping Jianfeng Cement Co., Ltd. to investigate and investigate, and preach the spirit of the Fifth Plenary Session of the 19th Central Committee of the Party. After visiting and understanding the company's production process, Sang Weiliang said happily: "I am very satisfied with the construction of a modern, clean and standardized cement production line in such a short period of time!" At the peak of Huang Ping, Sang Weiliang conveyed and preached the main contents of the spirit of the Fifth Plenary session of the 19th CPC Central Committee. He pointed out that governments at all levels in Qiandongnan Prefecture should thoroughly study and implement the spirit of the Fifth Plenary session of the 19th CPC Central Committee, earnestly implement the decisions and arrangements of the plenary session, focus on the main line of high-quality development, firmly grasp industrial projects, pay close attention to industrial economy, fully promote high-quality economic and social development, and strive to start a new journey of socialist modernization. We should persist in promoting the "four wheels" of new industrialization, we should pay close attention to the industrial economy, accelerate the transformation and upgrading of industrial industries, improve quality and efficiency, and strive to promote high-quality development and achieve stability and long-term development. During the investigation, Hu Hongwei, general manager of Huang Ping Jianfeng, introduced the basic situation of Jianfeng Group and Huang Ping Jianfeng to the state and county leaders, and focused on the equipment and process advantages of the production line, production process, production process, product quality control indicators, as well as various consumption indicators and emission indicators at the leading level in China. He also reported some problems and difficulties encountered after the formal operation of the enterprise. In view of the deficiencies in road traffic construction in Huangping County, Sang Weiliang asked the transportation department to strengthen communication, report and docking, strive for relevant support, do a solid job in the "14th Five-Year Plan" transportation development plan, further improve the road network connection and improve the transportation system, and provide strong support for the development of advantageous enterprises in Huangping Jianfeng and other regions. Sang Weiliang and his party also conducted in-depth research in the production workshop, checked the operation of the production line, and talked with the line staff. At the end of the investigation, he highly affirmed the construction and production work of Huang Ping Jianfeng for more than a year. The development of enterprises must take the road of sustainable development. It is necessary to ensure product quality and take into account the local ecology in order to develop in a long-term and sustainable manner. Sang Weiliang hopes that the Huangping County Government will do its best to ensure service, firmly establish a sense of service, and actively serve the enterprise. Serve, sincerely solve practical difficulties for the enterprise, create a good business environment, and help the enterprise achieve better development; also hope that Huang Ping Jianfeng will continue to play a pioneering role, jointly promote the high-quality economic and social development of Huangping County. (Pan Yi)
2020
12-22
Beirunning won the "13th Five-Year Chinese Medical Science and Technology Iconic Achievement" Award
From December 8 to 11, under the guidance of China Pharmacists Association, China over the counter drug Association and China Medical Education Association, the "2020 national pharmaceutical economic information conference and rice room annual meeting" sponsored by punctuation information (Group) was held in Guangzhou. During the event, the authoritative professional media of Chinese medicine, "Pharmaceutical Economics", released the list of "13th Five-Year China Pharmaceutical Science and Technology Iconic Achievements" and awarded the honorary certificate. The peak pharmaceutical product Berunning (Olopatadine Hydrochloride Eye Drops) is among them. Great changes have taken place in China's pharmaceutical industry during the 13th Five-Year Plan period. Drug review reform, consistency evaluation, volume procurement and other heavy policies in-depth promotion, driving the pharmaceutical industry innovation and upgrading. Chinese pharmaceutical leading enterprises take advantage of the trend, devote themselves to the development of new drugs, actively promote international registration, expand the international market, carry out international mergers and acquisitions, in the world life science stage blooming Chinese style. Lin Jianning, director of the Southern Institute of Pharmaceutical Economics of the State Drug Administration, combed the current operation of the pharmaceutical economy in detail and led the delegates to think deeply about the new changes in the pharmaceutical market in 2021. The industry authoritative media "Pharmaceutical Economic News" sponsored by the Southern Institute of Pharmaceutical Economics released the "13th Five-Year China Pharmaceutical Science and Technology Iconic Achievements" list during the event. The selection of this award aims to explore the scientific and technological achievements of China's pharmaceutical industry during the 13th five-year Plan period from the dimensions of scientific and technological innovation, clinical efficacy, market share and industry influence, so as to help transform pharmaceutical scientific and technological achievements. to help China move from a big pharmaceutical country to a pharmaceutical power. Pinnacle Pharmaceuticals' product, Berunning, is on the list. Berunning is the first eye drops to pass the consistency evaluation in China, and by virtue of its antagonistic histamine H1-receptor, stable mast cell two-way anti-allergy unique efficacy has been widely concerned. Beirunning in the treatment of children with allergic conjunctivitis has good effect, fast curative effect, will not cause significant mast cell degranulation, so the use of more safe, and almost no adverse reactions to the eye tissue, is the current treatment of allergic conjunctivitis an ideal drug. Since its launch in 2019, Berunning has received unanimous recognition and praise from domestic ophthalmologists. (Xu Yuting)
2020
12-22
On December 15, Xing Zhihong, deputy secretary of the Jinhua Municipal CPC Committee and acting mayor, accompanied by Cai Yan, secretary of the Wucheng District CPC Committee, Huang Guojun, and other leaders, visited the company for research, discussed and exchanged views with the company's management team, and put forward hope for the future development of Jianfeng as a leading enterprise in Jinhua City. Jiang Xiaomeng, chairman of the group company, introduced to Xing Zhihong and his party the development strategy, industrial layout, business performance in recent years, scientific and technological innovation, management innovation, as well as the work in charity, poverty alleviation and so on, which was fully affirmed by Xing Zhihong. Xing Zhihong said in the exchange that the peak is Jinhua's landmark enterprise and Jinhua's pride. It is not easy to stick to the industry for many years. Peak has a clear strategic direction and policy, and its good business performance in recent years has fully proved the courage and foresight of the management team. In view of the current situation that the pattern of economic competition at home and abroad is undergoing tremendous changes and the country's increasing requirements for environmental and ecological development, Xing Zhihong hopes that in the future work, Jianfeng will unswervingly follow the path of innovation and development, further increase investment in innovation and research and development, and further promote Green environmental protection production sets an example for Jinhua enterprises. He also hopes that the peak can "lay out the golden industry in the golden area", not only the enterprise itself through technological innovation to achieve high-quality development, but also further lead the upstream and downstream industries, attract potential and competitive enterprises to invest in Jinhua, forming a cluster effect. The municipal party committee and municipal government will also actively study and introduce better support policies to further optimize the business environment, so that enterprises can do a good job in production and operation without distractions, so that Jinhua can form a better industrial ecology. (this newspaper reporter)
2020
12-22